Antimicrobial and cytotoxic activities of natural (Z)-13-docosenamide derived from Penicillium chrysogenum
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1529104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Nashwa El-Gazzar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig, Egypt. Hauptthemen laut MEDLINE: Penicillium chrysogenum, Anti-Infective Agents, Antineoplastic Agents. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University.
Abstract (Originalsprache)
Introduction
The synthesis of natural compounds with strong biological activity from affordable sources has proven challenging for scientists. As a natural resource rich in a variety of bioactive substances, fungal metabolites have the potential to be used in medical applications to serve a global purpose towards a sustainable future.
Methods
A total of 25 filamentous fungi were isolated, and their secondary metabolites were assessed for their antimicrobial efficiency.
Results
The extracellular extract of the strain Penicillium chrysogenum Pc was selected for its high bioactivity compared with the other whole isolates. The GC-MS analysis of the extracellular extract of P. chrysogenum Pc was found to contain approximately 16 variable compounds. After several separation and purification processes using flash chromatography, HPLC, TLC, NMR, and FTIR, the most bioactive compound was identified as (Z)-13-docosenamide or erucylamide with a molecular formula of C22H43NO and a molecular weight of 337.0. The purified (Z)-13-docosenamide possessed antimicrobial activity with an MIC of approximately 10 μg/mL for the tested pathogenic bacteria ( Bacillus subtilis, Staphylococcus aureus, Klebsiella pneumoniae , and Escherichia coli ), and 20 μg/mL against the tested fungi ( Penicillium aurantiogriseum and Aspergillus fumigatus ). Furthermore, MTT assay showed that (Z)-13-docosenamide inhibited cellviability and the proliferation of hepatocellular carcinoma, in vitro, with an IC {sb}{/sb}50 of 23.8 ± 0.8 μg/mL.
Conclusion
The remarkable bioactivity of (Z)-13- docosenamide makes it a potential candidate to assist the pipeline for the creation of antibacterial and anticancer drugs, which will help to reduce the incidence of antimicrobial resistance (AMR) and fatalities related to cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig, Egypt.
- Botany and Microbiology Department, College of Science, King Saud University, Riyadh, Saudi Arabia.
- Genetics and Bioengineering Department, Faculty of Engineering and Natural Sciences, International University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Förderung
- King Saud University
Zitieren
APA
El-Gazzar, N., Said, L., Al-Otibi, F. O., AbdelGawwad, M. R., & Rabie, G. (2025). Antimicrobial and cytotoxic activities of natural (Z)-13-docosenamide derived from Penicillium chrysogenum. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1529104
Vancouver
El-Gazzar N, Said L, Al-Otibi FO, AbdelGawwad MR, Rabie G. Antimicrobial and cytotoxic activities of natural (Z)-13-docosenamide derived from Penicillium chrysogenum. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1529104
BibTeX
@article{ElGazzar2025,
author = {El-Gazzar, Nashwa and Said, Lekaa and Al-Otibi, Fatimah Olyan and AbdelGawwad, Mohamed Ragab and Rabie, Gamal},
title = {Antimicrobial and cytotoxic activities of natural (Z)-13-docosenamide derived from Penicillium chrysogenum},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1529104}
}
EUVIMED